Literature DB >> 6967362

[The role of radiotherapy and chemotherapy in the treatment of lymphomas].

B Ramot, I Ben-Bassat.   

Abstract

Entities:  

Mesh：

Year:  1980        PMID： 6967362      PMCID： PMC2395789     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN： 0042-9686            Impact factor:   9.408


× No keyword cloud information.
  7 in total

1.  No initial therapy for stage III and IV non-Hodgkin's lymphomas of favorable histologic types.

Authors:  C S Portlock; S A Rosenberg
Journal:  Ann Intern Med       Date:  1979-01       Impact factor: 25.391

Review 2.  Combination therapy of the lymphomas.

Authors:  B J Lewis; V T DeVita
Journal:  Semin Hematol       Date:  1978-10       Impact factor: 3.851

3.  Combination chemotherapy in the treatment of advanced Hodgkin's disease.

Authors:  V T Devita; A A Serpick; P P Carbone
Journal:  Ann Intern Med       Date:  1970-12       Impact factor: 25.391

4.  Chemotherapy of localised histiocytic lymphoma.

Authors:  T P Miller; S E Jones
Journal:  Lancet       Date:  1979-02-17       Impact factor: 79.321

5.  Sequential nonsurgical and surgical staging of non-Hodgkin's lymphoma.

Authors:  B A Chabner; R E Johnson; R C Young; G P Canellos; S P Hubbard; S K Johnson; V T DeVita
Journal:  Ann Intern Med       Date:  1976-08       Impact factor: 25.391

6.  Prognostic classification of Hodgkin disease in pathologic stage III, based on anatomic considerations.

Authors:  R K Desser; H M Golomb; J E Ultmann; D J Ferguson; E M Moran; M L Griem; J Vardiman; B Miller; N Oetzel; D Sweet; E P Lester; J J Kinzie; R Blough
Journal:  Blood       Date:  1977-06       Impact factor: 22.113

7.  Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP.

Authors:  G Bonadonna; R Zucali; S Monfardini; M De Lena; C Uslenghi
Journal:  Cancer       Date:  1975-07       Impact factor: 6.860
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.